Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine and potentially other addictions, today announced that the first subjects have begun dosing of EMB-001 in a Phase 2 study for cocaine use disorder. EMB-001 is being tested to help patients struggling with addiction to maintain abstinence and improve their quality of life by simultaneously targeting multiple neurological pathways that play a role in stress-induced, cue-induced and drug-induced addiction relapse. Embera is developing the first medication that treats addiction by moderating activity in the stress response system.
On February 2, 2018, Premier Biotech Inc. was granted a coveted 510(k) clearance for the following drugs Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates and Phencyclidine from the Food and Drug Administration (FDA) for OralTox®, its flagship, patented rapid oral fluid drug screen device. A FDA 510(k) clearance is a significant achievement as it paves the way for distribution and utilization in clinical markets and allows for further expansion in the employment sector.
Camino Pharma, LLC, a new start-up company focusing on finding cures for cancer and brain disorders, announced today that its Co-founder and Head of Drug Discovery, Nicholas Cosford, Ph.D., has been awarded a three-year, $10.8 million grant by the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH). The grant will fund a collaborative effort between the Sanford Burnham Prebys Medical Research Institute (SBP), UC San Diego and Camino Pharma, LLC to advance the preclinical development of a new class of medicine for the treatment of substance use disorders, including cocaine and nicotine addiction.
Provincial officials will conduct an inspection of the Windsor police drug vault after the disappearance of $25,000 worth of cocaine seized nearly four years ago.
Minister of Health, Prof. Isaac Adewole, who said the Nigerian Customs Service (NCS) and NAFDAC seized the products valued at N9.6 billion, stressed that nothing destroys a nation than the importation, distribution and consumption of fake items.
So the RCMP and China’s Ministry of Public Security have announced they will work together to combat the surge of fentanyl and other opioids flowing from China into Canada. The need for action is undoubtedly urgent. Fentanyl has been the instrument of death for hundreds of heroin and cocaine users in Canada, and CSIS intelligence suggests almost all the fentanyl comes from small synthetic chemical factories all over China.
DEA Proposes to Remove Cocaine Derivative [123I]Ioflupane from Schedule II of the CSA – Almost Five Years after Receipt of HHS’s Recommendation
Cody Laboratories, Inc., Ongoing Class II recall of C-Topical 4% CII (cocaine hydrochloride), topical solution, 4 ml bottle, (NDC 0527-1728-74), Rx Only, Manufactured for Lannett Company, Inc. Philadelphia, PA 19136 by Cody Laboratories, Inc. Cody, WY 82414 because of Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL